The Value of Sentinel Node Biopsy in Patients With Higher-Risk (T3, T4) Primary Cutaneous Melanomas: Insights Provided by a Stage II Risk Calculator.

Pennington TE, Thompson JF, Saw RPM, Coker DJ, Lo SN, Varey AHR. Annals of Surgical Oncology, (May 02 2025), doi:10.1245/s10434-024-16699-3

No abstract available